| 1. |
Tobias W, Mikkelsen T. Recurrent high-grade glioma:a diagnostic and therapeutic challenge[J]. Expert Rev Neurother, 2011, 11(4): 509-518.
|
| 2. |
Fang YJ, Lu ZH, Wang F, et al. Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer[J]. Tumour Biol, 2010, 31(6): 651-658.
|
| 3. |
Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma[J]. Arch Neurol, 2010, 67(3): 279-283.
|
| 4. |
Morrison CJ, Butler GS, Rodríguez D, et al. Matrix metalloproteinase proteomics: substrates, targets, and therapy[J]. Curr Opin Cell Biol, 2009, 21(5): 645-653.
|
| 5. |
Fukuda A, Wang SC, Morris JP 4th, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression[J]. Cancer Cell, 2011, 19(4): 441-455.
|
| 6. |
Kim JH, Eom DY, Kim CW, et al. Expression of E-cadherin,beta-catenin,Cdx2 and MMP7 in pT2 and N1/N2 gastric cancer:relationship with tumor recurrence within 2-year period[J]. J Korean Surg Soc, 2011, 80(1): 29-35.
|
| 7. |
楊波, 王志新. MMP-7反義寡核苷酸抑制肺腺癌A549細胞體外增殖活性的實驗研究[J]. 第三軍醫大學學報, 2007, 29(3): 250-252.
|
| 8. |
楊波, 唐伏秋, 高建飛, 等. MMP7反義寡核苷酸對肺腺癌A549細胞粘附和侵襲能力的影響[J]. 重慶醫科大學學報, 2010, 35(8): 1160-1163.
|
| 9. |
楊波, 王志新. 反義寡核苷酸抑制MMP7基因表達對肺腺癌A549細胞凋亡敏感性影響的研究[J]. 華南國防醫學雜志, 2007, 21(6): 21-26.
|
| 10. |
Fingleton B, Vargo-Gogola T, Crawford HC, et al. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis[J]. Neoplasia, 2001, 3(6): 459-468.
|
| 11. |
徐飛, 王志新, 陳正堂. 非小細胞肺癌組織基質溶解素的表達與微血管密度的關系[J]. 重慶醫學, 2004, 33(7): 994-996.
|
| 12. |
張金燦, 賀建平, 賀禮進, 等. VEGF和MMP-7在不同病理級別膠質瘤中的表達及臨床意義 [J]. 中國現代醫生, 2010, 48(10): 30-33.
|
| 13. |
潘旭波, 紀祥瑞, 姜蕾, 等. β-catenin、MMP-7蛋白在不同級別膠質瘤組織中的表達及臨床意義[J]. 實用癌癥雜志, 2007, 22(2): 164-166.
|